Cargando…

A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomy

The optimal post-operative adjuvant treatment for completely resected gastric cancer with D2 lymphadenectomy remains controversial. The present study was a phase II trial on post-operative chemoradiotherapy in 30 patients with gastric cancer. Patients with stage II to IV (M0) gastric cancer received...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHAI, YU-JIE, SU, YI-PENG, WANG, SHENG-JIE, NING, FANG-LING, WANG, ZHEN-BO, YU, WEN-ZHENG, CHEN, SHAO-SHUI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156225/ https://www.ncbi.nlm.nih.gov/pubmed/25202423 http://dx.doi.org/10.3892/ol.2014.2382

Ejemplares similares

Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis
por: Huang, Yuan-Yuan, et al.
Publicado: (2013)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
por: Yang, Qiong, et al.
Publicado: (2013)

Correction: Postoperative Chemoradiotherapy versus Postoperative Chemotherapy for Completely Resected Gastric Cancer with D2 Lymphadenectomy: A Meta-Analysis
por: Huang, Yuan-Yuan, et al.
Publicado: (2013)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2022)

Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy
por: Jácome, Alexandre A. A., et al.
Publicado: (2012)

Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
por: Zhang, Zheng, et al.
Publicado: (2022)

Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study
por: Scholte, Mirre, et al.
Publicado: (2020)

Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
por: Larciprete, Giovanni, et al.
Publicado: (2013)

Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis
por: Chen, Jiuzhou, et al.
Publicado: (2022)

D2 lymphadenectomy with complete mesogastrium excision vs. conventional D2 gastrectomy for advanced gastric cancer
por: Meng, Xiangyu, et al.
Publicado: (2022)

Rationale for extensive lymphadenectomy in early gastric carcinoma.
por: Miwa, K., et al.
Publicado: (1995)

Favoring D(2)-Lymphadenectomy in Gastric Cancer
por: Karavokyros, Ioannis, et al.
Publicado: (2018)

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy
por: Peng, Jian-Hong, et al.
Publicado: (2018)

Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer
por: Wei, Li-Chun, et al.
Publicado: (2018)

Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center
por: Costa, Wilson L, et al.
Publicado: (2012)

The Impact of Age on the Post-operative Outcomes in Patients Undergoing Resection for Oesophageal and Gastric Cancer
por: Law, Cameron, et al.
Publicado: (2023)

Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
por: Li, Jian, et al.
Publicado: (2020)

Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
por: Takeuchi, Hiroya, et al.
Publicado: (2010)

Learning Curve for D2 Lymphadenectomy in Gastric Cancer
por: Luna, Alexis, et al.
Publicado: (2013)

Is There Any Role for D3 Lymphadenectomy in Gastric Cancer?
por: Douridas, Gerassimos N., et al.
Publicado: (2018)

The effects of intra- and post-operative anaesthesia and analgesia choice on outcome after gastric cancer resection: a retrospective study
por: Wang, Yu, et al.
Publicado: (2017)

Immune Score Predicts Outcomes of Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy
por: Zou, Wei, et al.
Publicado: (2021)

Fluorescent Lymphography-Guided Lymphadenectomy during Minimally Invasive Completion Total Gastrectomy for Remnant Gastric Cancer Patients
por: Alrashidi, Nasser, et al.
Publicado: (2022)

Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial
por: Shen, Jie, et al.
Publicado: (2018)

Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis
por: Sun, Weilin, et al.
Publicado: (2020)

Evaluation of rational extent lymphadenectomy for local advanced gastric cancer
por: Liang, Han, et al.
Publicado: (2016)

A combined approach for individualized lymphadenectomy in gastric cancer patients
por: Varga, Zsolt, et al.
Publicado: (2023)

Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival
por: Kauppila, Joonas H., et al.
Publicado: (2017)

Patterns of regional nodal relapse after D2 lymphadenectomy in gastric cancer: rethinking the target volume
por: Yang, Wang, et al.
Publicado: (2018)

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy
por: Grau, Juan J, et al.
Publicado: (2006)

Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Li, Chao, et al.
Publicado: (2022)

Assessment of quality of life in resectable gastric cancer patients undergoing chemoradiotherapy as adjuvant treatment
por: Pruthi, Deep Shankar, et al.
Publicado: (2018)

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
por: Che, Keying, et al.
Publicado: (2020)

Application of lymphangiography in para-aortic lymphadenectomy for ovarian cancer
por: Xu, Zhen, et al.
Publicado: (2021)

Lymphadenectomy Benefits Small Cell Carcinoma of Ovary: A Population-Based Analysis
por: Wang, Jing, et al.
Publicado: (2022)

Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma
por: Liu, Yong, et al.
Publicado: (2018)

Lymphadenectomy is Unnecessary for Pure Ground-Glass Opacity Pulmonary Nodules
por: Lin, Yi-Han, et al.
Publicado: (2020)

Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma
por: Schmalbach, Cecelia E., et al.
Publicado: (2018)

Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer
por: Pai, Chu-Pin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1qdjqderuba86jn31988ha571j